RORgamma Agonists Enhance Survival and Memory of Type 17 T Cells and Improve Anti-Tumor Activity
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-3-s2-p23
Full Text
Open PDFAbstract
Available in full text
Date
November 4, 2015
Authors
Publisher
BMJ